Carregando...
Two cases of liver cirrhosis treated with lusutrombopag before partial splenic embolization
Lusutrombopag, a small molecule thrombopoietin receptor agonist, has been approved for the treatment of chronic liver disease-associated thrombocytopenia due to hypersplenism in patients scheduled to undergo elective invasive procedures in Japan. We performed partial splenic embolization (PSE) after...
Na minha lista:
| Publicado no: | Fukushima J Med Sci |
|---|---|
| Principais autores: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Fukushima Society of Medical Science
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5792501/ https://ncbi.nlm.nih.gov/pubmed/29142151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5387/fms.2017-07 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|